PCI

PCI Evolution in Infiltrative Diseases

Infiltrative diseases (ID) consist of a heterogeneous series of genetic conditions that cause infiltration and extracellular deposits which alter the diverse systems and organs affected.&nbsp;&nbsp;&nbsp; Amyloidosis, sarcoidosis and hemochromatosis affect the heart, altering the myocardium and the conduction system.&nbsp; PCI is often used at present to treat heart disease, and some of these patients present<a href="https://solaci.org/en/2024/02/21/pci-evolution-in-infiltrative-diseases/" title="Read more" >...</a>

Disnea y oclusiones totales crónicas: un síntoma que podemos aliviar (o al menos intentarlo)

Contemporary Outcomes of CTO PCI in Europe: The ERCTO Registry

Roughly 20% or coronary angiographies show some form of chronic total occlusion (CTO), and this figure is twice as high for diabetic patients or those with cardiac failure and reduced ejection fraction (EF). CTO percutaneous intervention (PCI) has experienced a significant growth thanks to the development of new techniques and dedicated material. However, a considerable<a href="https://solaci.org/en/2024/02/08/contemporary-outcomes-of-cto-pci-in-europe-the-ercto-registry/" title="Read more" >...</a>

¿Es frecuente el uso de IVUS para guiar la ATC?

Use of IVUS in Complex PCI: Results according to Operator Experience

The use of ultravascular ultrasound (IVUS) to guide coronary angioplasty procedures (PCI) has been shown to reduce the risk of major adverse events in numerous randomized controlled studies, registries and meta-analysis.&nbsp; The current guidelines recommend the use of IVUS in left main disease and complex lesions. The proportion of complex PCI procedures has increased over<a href="https://solaci.org/en/2024/01/09/use-of-ivus-in-complex-pci-results-according-to-operator-experience/" title="Read more" >...</a>

ATC guiada por iFR ¿es igual en la DA que en el resto de los vasos?

iFR Guided PCI to the LAD: Same as for non-LAD Vessels?

iFR has been validated as a useful tool for intermediate lesion analysis, with the advantage of not requiring the use of drugs. On the other hand, its use for PCI outcome assessment has not yet been thoroughly looked into, even though there have been promising data.&nbsp; 24% of DEFINE PCI cases presented ≤0.89 iFR with<a href="https://solaci.org/en/2023/12/07/ifr-guided-pci-to-the-lad-same-as-for-non-lad-vessels/" title="Read more" >...</a>

La complejidad de la angioplastia puede definir el tiempo de doble antiagregación

Optimal Duration of DAPT with Oral Anticoagulation After PCI?: 1 Month vs. 3 Months

While the benefits of dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor are recognized, its primary complication is the occurrence of bleeding events, which negatively impact patient morbidity and mortality. Additionally, about 10% of patients undergoing percutaneous coronary intervention (PCI) are on oral anticoagulant therapy, which significantly increases the risk of bleeding when<a href="https://solaci.org/en/2023/11/23/optimal-duration-of-dapt-with-oral-anticoagulation-after-pci-1-month-vs-3-months/" title="Read more" >...</a>

AHA 2023

AHA 2023 | ORBITA-2: PCI vs. Placebo in Stable Angina for Symptom Reduction

In patients with stable chronic angina, percutaneous coronary intervention (PCI) is often conducted to relieve symptoms. However, there is still some uncertainty regarding whether PCI provides superior symptomatic relief compared with a placebo in patients not receiving anti-anginal medication. Researchers conducted a controlled and randomized study in which patients with stable angina discontinued all anti-anginal<a href="https://solaci.org/en/2023/11/14/aha-2023-orbita-2-pci-vs-placebo-in-stable-angina-for-symptom-reduction/" title="Read more" >...</a>

Left Main Coronary Artery PCI: In What Scenario Could We Not Use IVUS?

Lesions in the left main coronary artery (LMCA) continue to pose a significant challenge. The use of coronary imaging before percutaneous coronary implantation (PCI) has proven useful in analyzing the lesion, identifying the presence and location of calcification, and determining lesion length in the LMCA, the left anterior descending artery, and the circumflex artery. Various<a href="https://solaci.org/en/2023/10/10/left-main-coronary-artery-pci-in-what-scenario-could-we-not-use-ivus/" title="Read more" >...</a>

indicación de tratamiento con estatinas

Anti-Lipid Therapy in PCI Patients: Monotherapy with Statins or Combination?

According to several studies, in patients with high-risk atherosclerotic disease, such as those affected by coronary artery disease, achieving target LDL levels through high-intensity statin therapy has been shown to lead to a significant reduction in long-term cardiovascular events. Therefore, the management of dyslipidemia has become a fundamental pillar of secondary prevention. However, reaching such<a href="https://solaci.org/en/2023/10/04/anti-lipid-therapy-in-pci-patients-monotherapy-with-statins-or-combination/" title="Read more" >...</a>

Top